谷氨酸受体
突触素
微透析
转基因小鼠
淀粉样前体蛋白
星形胶质细胞
胶质纤维酸性蛋白
刺激
内科学
内分泌学
野生型
生物
转基因
化学
神经科学
阿尔茨海默病
医学
生物化学
中枢神经系统
免疫组织化学
突变体
受体
疾病
基因
作者
Rimante Minkeviciene,Jouni Ihalainen,Tarja Malm,Olli Matilainen,Velta Keksa-Goldsteine,Gundars Goldsteins,H. Iivonen,N. Leguit,Jeffrey Glennon,Jari Koıstınaho,Pradeep Banerjee,Heikki Tanila
标识
DOI:10.1111/j.1471-4159.2007.05147.x
摘要
Abstract We assessed baseline and KCl‐stimulated glutamate release by using microdialysis in freely moving young adult (7 months) and middle‐aged (17 months) transgenic mice carrying mutated human amyloid precursor protein and presenilin genes (APdE9 mice) and their wild‐type littermates. In addition, we assessed the age‐related development of amyloid pathology and spatial memory impaired in the water maze and changes in glutamate transporters. APdE9 mice showed gradual spatial memory impairment between 6 and 15 months of age. The stimulated glutamate release declined very robustly in 17‐month‐old APdE9 mice as compared to 7‐month‐old APdE9 mice. This age‐dependent decrease in stimulated glutamate release was also evident in wild‐type mice, although it was not as robust as in APdE9 mice. When compared to individual baselines, all aged wild‐type mice showed 25% or greater increase in glutamate release upon KCl stimulation, but none of the aged APdE9 mice. There was an age‐dependent decline in VGLUT1 levels, but not in the levels of VGLUT2, GLT‐1 or synaptophysin. Astrocyte activation as measured by glial acidic fibrillary protein was increased in middle‐aged APdE9 mice. Blunted pre‐synaptic glutamate response may contribute to memory deficit in middle‐aged APdE9 mice.
科研通智能强力驱动
Strongly Powered by AbleSci AI